DGI:Gram-positive Bakterien/Quellen: Difference between revisions
imported>Bestem (Die Seite wurde neu angelegt: „== Quellen ==“) |
imported>Bestem |
||
| Line 1: | Line 1: | ||
== Quellen == | ==Quellen== | ||
'''''<span class="ve-pasteProtect" style="font-size:12.0pt;line-height:107%;font-family:"Times New Roman",serif; | |||
mso-ansi-language:EN-US" data-ve-attributes="{"style":"font-size:12.0pt;line-height:107%;font-family:\"Times New Roman\",serif;\nmso-ansi-language:EN-US"}">Enterokokken</span>''''' | |||
<span class="ve-pasteProtect" style="font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-font-family: | |||
"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:DE" data-ve-attributes="{"style":"font-size:12.0pt;font-family:\"Times New Roman\",serif;mso-fareast-font-family:\n\"Times New Roman\";mso-ansi-language:EN-US;mso-fareast-language:DE"}">Kramer TS, Remschmidt C, Werner S, Behnke M, Schwab F, Werner G, Gastmeier P, Leistner R. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections. Antimicrob Resist Infect Control. 2018 Nov 14;7:133. doi: 10.1186/s13756-018-0419-9. PMID: 30459945; PMCID: PMC6234683.</span> | |||
<span class="ve-pasteProtect" style="font-size:12.0pt;line-height:107%;font-family: | |||
"Times New Roman",serif;mso-ansi-language:EN-US" data-ve-attributes="{"style":"font-size:12.0pt;line-height:107%;font-family:\n\"Times New Roman\",serif;mso-ansi-language:EN-US"}">Raza T, Ullah SR, Mehmood K, Andleeb S. Vancomycin resistant Enterococci: A brief review.</span> J Pak Med Assoc. 2018 May;68(5):768-772. PMID: 29885179 | |||
<span class="ve-pasteProtect" style="font-size:12.0pt;line-height:107%;font-family: | |||
"Times New Roman",serif;mso-ansi-language:EN-US" data-ve-attributes="{"style":"font-size:12.0pt;line-height:107%;font-family:\n\"Times New Roman\",serif;mso-ansi-language:EN-US"}">Rosselli Del Turco E, Bartoletti M, Dahl A, Cervera C, Pericàs JM. How do I manage a patient with enterococcal bacteraemia? Clin Microbiol Infect. 2020 Nov 2:S1198-743X(20)30660-1. doi: 10.1016/j.cmi.2020.10.029. Epub ahead of print. PMID: 33152537.</span> | |||
<span class="ve-pasteProtect" style="font-size:12.0pt;line-height:107%;font-family: | |||
"Times New Roman",serif;mso-ansi-language:EN-US" data-ve-attributes="{"style":"font-size:12.0pt;line-height:107%;font-family:\n\"Times New Roman\",serif;mso-ansi-language:EN-US"}">Dahl A, Lauridsen TK, Arpi M, Sørensen LL, Østergaard C, Sogaard P, et al.</span> Risk factors of endocarditis in patients with Enterococcus faecalis bacteremia: external validation of the NOVA score. Clin Infect Dis 2016;63:771e5. | |||
Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis. <span class="ve-pasteProtect" style="font-size:12.0pt;line-height:107%;font-family:"Times New Roman",serif; | |||
mso-ansi-language:EN-US" data-ve-attributes="{"style":"font-size:12.0pt;line-height:107%;font-family:\"Times New Roman\",serif;\nmso-ansi-language:EN-US"}">Clin Infect Dis. 2013 May;56(9):1261-8.</span> | |||
<br /> | |||
Latest revision as of 12:31, 18 May 2021
Quellen
Enterokokken
Kramer TS, Remschmidt C, Werner S, Behnke M, Schwab F, Werner G, Gastmeier P, Leistner R. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections. Antimicrob Resist Infect Control. 2018 Nov 14;7:133. doi: 10.1186/s13756-018-0419-9. PMID: 30459945; PMCID: PMC6234683.
Raza T, Ullah SR, Mehmood K, Andleeb S. Vancomycin resistant Enterococci: A brief review. J Pak Med Assoc. 2018 May;68(5):768-772. PMID: 29885179
Rosselli Del Turco E, Bartoletti M, Dahl A, Cervera C, Pericàs JM. How do I manage a patient with enterococcal bacteraemia? Clin Microbiol Infect. 2020 Nov 2:S1198-743X(20)30660-1. doi: 10.1016/j.cmi.2020.10.029. Epub ahead of print. PMID: 33152537.
Dahl A, Lauridsen TK, Arpi M, Sørensen LL, Østergaard C, Sogaard P, et al. Risk factors of endocarditis in patients with Enterococcus faecalis bacteremia: external validation of the NOVA score. Clin Infect Dis 2016;63:771e5.
Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013 May;56(9):1261-8.